| Literature DB >> 23408136 |
Fatemeh Hajighasemi1, Jalal Khoshnoodi, Fazel Shokri.
Abstract
BACKGROUND: Pan-IgG specific monoclonal antibodies (MAbs) are essential tools for assessment of humoral immunity, immune deficiency and gammopathy. In this study, four hybridoma clones producing MAbs with different specificities for human IgG isotypes were established.Entities:
Keywords: Enzyme linked immunosorbent assay; Hybridomas; Immunoglobulin isotypes; Monoclonal antibody
Year: 2012 PMID: 23408136 PMCID: PMC3558227
Source DB: PubMed Journal: Avicenna J Med Biotechnol ISSN: 2008-2835
Reactivity of selected hybridoma clones with human Ig isotypes, polyclonal IgG and IgG subclasses
| Screening antigen | OD (492 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Hybridoma | IgM | IgA | IgD | IgE | Polyclonal IgG | IgG1 | IgG2 | IgG3 | IgG4 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
| 1.5 | 1.6 | 1.9 | 1.6 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
| 1.6 | 1.4 | 1.4 | 1 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
| 1.8 | 1.7 | 1.6 | 1.4 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
| 1.4 | 1 | 1.2 | 1.4 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
|
| 0.27 | 0.3 | 0.27 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
| 0.4 |
| 0.3 | 0.25 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
| 0.3 | 0.3 |
| 0.3 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
| 0.3 | 0.3 | 0.3 |
|
* Positive reactivity is shown in bold figures. Commercial IgG subclass monospecific MAbs, including JL512 (IgG1), GOM2 (IgG2), ZG4 (IgG3) and RJ4 (IgG4), are included as control MAbs for each IgG subclass
Determination of the isotype of monoclonal antibodies by ELISA
| Isotype MAbs | IgG1 | IgG2a | IgG2b | IgG3 | IgA | IgM |
|---|---|---|---|---|---|---|
|
|
| 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
|
|
| 0.2 | 0.2 | 0.17 | 0.17 | 0.18 |
|
|
| 0.2 | 0.2 | 0.17 | 0.18 | 0.2 |
|
|
| 0.2 | 0.1 | 0.1 | 0.1 | 0.2 |
|
| 0.16 | 0.14 | 0.1 | 0.15 | 0.1 | 0.16 |
Control– : Culture supernatant from SP2/0 myeloma cells. The results represent OD values obtained at 492 nm
Figure 1Reactivity patterns of pan-IgG specific monoclonal antibodies with human IgG subclasses
Figure 2Immunoblot analysis of 3F2D8 monoclonal antibody reactivity with human IgG subclasses. Lanes 1 to 4 represent reduced forms of IgG1, IgG2, IgG3 and IgG4 paraproteins, respectively. Lanes 5 to 7 represent non reduced forms of whole molecule, Fab and Fc fragments of IgG1. Lanes 8 to 10 represent non reduced forms of IgG2, IgG3 and IgG4 paraproteins, respectively
Figure 3Reactivity of pan-IgG specific monoclonal antibodies with enzymatic fragments of IgG. Control represents a mouse monoclonal antibody (8a4) with anti human pan-IgG specificity
Cross-reactivity of monoclonal antibodies with animal sera
| Animal sera | Cross-reactivity% | |||
|---|---|---|---|---|
|
| ||||
| 3F2D8 | 1F4C4 | 8F9A8 | 5F19G11 | |
|
| 100 | 100 | 66 | 84 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
|
|
| <0.1 | <0.1 | <0.1 |
|
| <0.1 |
| <0.1 | <0.1 |
|
| <0.1 | <0.1 | <0.1 | <0.1 |
% Cross-reactivity is expressed relative to the value obtained for human pooled serum
Figure 4Representative binding curves employed for extrapolation of affinity constant of 3F2D8 (A) and 5F19G11 (B) monoclonal antibodies
Affinity constant of human pan-IgG specific monoclonal antibodies determined by ELISA
| MAbs | [Ag] ( | OD-50 | [Ab] at OD-50 ( | Affinity constant ( | Average affinity constant ( |
|---|---|---|---|---|---|
|
| |||||
| 5000 | 0.69 | 700 | 0.68×108 | 0.74×108 | |
| 2500 | 0.64 | 900 | 0.8×108 | ||
| 1250 | 0.54 | 920 | 0.75×108 | ||
|
| |||||
| 5000 | 1.1 | 6400 | 0.99×107 | 0.96×107 | |
| 2500 | 1 | 7000 | 0.94×107 | ||
| 1250 | 0.9 | 7500 | 0.95×10 7 | ||
OD-50 represents the half maximum optical density obtained for a given concentration of h-IgG ([Ag]) and the corresponding MAb ([Ab]). The affinity constant for each selected concentration of Ag and Ab was determined using the formula described in the Materials and Methods